Parametric Portfolio Associates’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Parametric Portfolio Associates’s Portfolio SGNT Stock Details SGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-20,796	Closed	-$312K	–	3852
2016 Q2	$312K	Buy	20,796 +413	+2%	+$5.31K	﹤0.01%	3435
2016 Q1	$248K	Sell	20,383 -4,303	-17%	-$60.3K	﹤0.01%	3674
2015 Q4	$393K	Buy	+24,686	New	+$389K	﹤0.01%	3409
2015 Q1	–	Sell	-9,282	Closed	-$233K	–	4049
2014 Q4	$233K	Sell	9,282 -2,721	-23%	-$79.8K	﹤0.01%	3707
2014 Q3	$373K	Buy	+12,003	New	+$325K	﹤0.01%	3370

Parametric Portfolio Associates's SGNT Position: Q3 2016 in Review

Parametric Portfolio Associates sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 20,796 shares — an estimated $312K sold.

Parametric Portfolio Associates first reported a position in SGNT in Q3 2014 and held it in 5 quarters. The position peaked at $393K in Q4 2015. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

Parametric Portfolio Associates reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
Parametric Portfolio Associates sold 20,796 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $312K.
Parametric Portfolio Associates first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q3 2014 and held it in 5 quarters.
Parametric Portfolio Associates's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $393K in Q4 2015.
0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Parametric Portfolio Associates's 13F filing for Q3 2016, filed 14 Nov 2016.